IDXX Stock Recent News

IDXX LATEST HEADLINES

IDXX Stock News Image - Business Wire

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 29, 10:50 am – 11:30 am EST – Brian McKeon, Executive Vice President and Chief Financial Officer, and Tina Hunt, PhD, Executive Vice President, Strategy, Sector Development and Global Operations, will participate in a fireside chat at the BofA Securities Animal Health Virtual Summit. Monday, March 4, 11:00 am –.

Business Wire 2024 Feb 20
IDXX Stock News Image - Zacks Investment Research

IDEXX's (IDXX) Vello software is an intuitive solution designed specifically for practice management software that enables practitioners to interact with pet owners before and after visits.

Zacks Investment Research 2024 Feb 16
IDXX Stock News Image - Zacks Investment Research

IDEXX Laboratories, Inc. IDXX is likely to grow in the coming quarters, backed by the sustained success of CAG's recurring diagnostic products and services. The company's international business performance is gaining from its expanded global commercial capability.

Zacks Investment Research 2024 Feb 15
IDXX Stock News Image - Zacks Investment Research

A key element of IDEXX's (IDXX) customer engagement strategy is the expansion of its commercial footprint in a disciplined approach.

Zacks Investment Research 2024 Feb 08
IDXX Stock News Image - Seeking Alpha

IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript

Seeking Alpha 2024 Feb 05
IDXX Stock News Image - Zacks Investment Research

Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter.

Zacks Investment Research 2024 Feb 05
IDXX Stock News Image - Zacks Investment Research

While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research 2024 Feb 05
IDXX Stock News Image - Zacks Investment Research

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $2.05 per share a year ago.

Zacks Investment Research 2024 Feb 05
IDXX Stock News Image - Zacks Investment Research

IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research 2024 Feb 02
IDXX Stock News Image - Zacks Investment Research

Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research 2024 Jan 31
10 of 50